RecruitingNCT05776056
Methylphenidate or placebo for PTSD and cognitive concerns in veterans
About this title
Read the official source — NCT05776056Medication studyAges 18–65United States
Understand this study
Who could participate?
This study is for people with PTSD. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
What will I do during this study?
Each participant receives both methylphenidate and placebo (an inactive comparison treatment) in randomized order across four treatment blocks, with a one-week washout between blocks.
- Listed locations
- Birmingham and 2 more locationsSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: February 5, 2024
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 70
- Sponsor
- VA Office of Research and Development
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT05776056
- Official title
Show the full official title
Randomized Placebo-Controlled Trial of Methylphenidate for the Treatment of Post-Traumatic Stress Disorder With Associated Neurocognitive Complaints
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Birmingham · Tuscaloosa · Seattle
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is VA Office of Research and Development, a government agency.
Does this study involve medication?
Yes. The study involves medication, including Methylphenidate and Placebo.
Who can participate?
This study is for people with PTSD. Listed age limits: 18 years to 65 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
